(AP) CINCINNATI, OH - Major news breaking with wide-reaching impacts.
That was the feeling when the news broke that WIS-HBD will be taking its lead from Major League Baseball in a new, stronger, unified stance on performance-enhancing drugs. The reprecussions will surely be felt with this news coming on the eve of the first season in Moneyball.
With dozens of aging stars suddenly exceeding the numbers they put up in their prime, there was little outcry from owners, but a small rumbling finally gained enough steam to catch the eyes and ears of the WIS-HBD offices.
However, the one-year contracts that typically caused aging vets to consider various performance-enhancing drugs have also recently been publicly chastized by the player's union, and the players themselves are increasingly turning down the short-term security to test the FA market.
How these major changes to the landscape for 30-something players will affect GM decisions remains unclear, but with the cutthroat rules of Moneyball should provide us with a good idea of how the prevailing winds will start to blow.